Florent Grange
Centre Hospitalier Universitaire de Reims(FR)Hôpital Robert-Debré(FR)Centre Hospitalier de Valence(FR)Université de Reims Champagne-Ardenne(FR)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, Cutaneous Melanoma Detection and Management, Lymphoma Diagnosis and Treatment, Nonmelanoma Skin Cancer Studies, Melanoma and MAPK Pathways
Most-Cited Works
- → Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib(2014)2,622 cited
- → Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial(2017)569 cited
- → A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma(2011)515 cited
- → Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial(2017)487 cited
- → Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin(2011)461 cited
- → Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial